Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with (90)Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer

The poor prognosis of pancreatic cancer requires the development of more effective therapy. CD147 expresses in pancreatic cancer with high incidence and has a crucial role in invasion and metastasis. We developed a fully human monoclonal antibody (059-053) with high affinity for CD147. Here we evalu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Mol Sci
Asıl Yazarlar: Sugyo, Aya, Tsuji, Atsushi B., Sudo, Hitomi, Koizumi, Mitsuru, Ukai, Yoshinori, Kurosawa, Gene, Kurosawa, Yoshikazu, Saga, Tsuneo, Higashi, Tatsuya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213240/
https://ncbi.nlm.nih.gov/pubmed/30274301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19102979
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller